| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $785.0M | $824.2M | $917.0M |
| YoY Revenue Growth % | -4.7% | -10.1% | — |
| Gross Profit | $532.7M | $537.2M | — |
| Gross Margin % | 67.9% | 65.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $56.7M | -$33.3M | -$200.0M |
| Operating Margin % | 7.2% | -4.0% | -21.8% |
| Net Income (GAAP) | $307.0K | -$74.2M | -$259.3M |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $63.5M | $89.8M | $148.2M |
| Capital Expenditures (CapEx) | — | — | — |
| Free Cash Flow (FCF) | $63.5M | $89.8M | $148.2M |
| FCF Margin % | 8.1% | 10.9% | 16.2% |
| Return on Invested Capital (ROIC %) | 10.1% | -5.8% | — |
| Cash & Short-Term Equivalents | $10.8M | $16.3M | — |
| Total Debt (Short + Long Term) | $236.0M | $271.2M | — |
| Total Stockholders' Equity | $218.1M | $196.9M | — |